Enda Brady: UK correspondent on research revealing Ozempic reduces chances of heart attacks by 20 percent

Researchers have found the injectable weight-loss treatment Ozempic could reduce the risk of heart attacks across the UK. A study revealed semaglutide, a key ingredient in treatments including Wegovy and Ozempic could likely boost the cardiovascular health of millions. UK correspondent Enda Brady says it's likely Ozempic will be routinely prescribed in the UK by the end of the decade.   LISTEN ABOVESee omnystudio.com/listener for privacy information.